This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Mucinosis of skin
L12_MUCINOSISOFSKIN
skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
37 |
4. Check minimum number of eventsNone |
37 |
5. Include endpointsNone |
37 |
6. Filter based on genotype QC (FinnGen only) |
37 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L98
- Name in latin
- Mucinosis cutis
Similar endpoints
↥List of similar endpoints to
Mucinosis of skin
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Paracetamol of NSAID medication
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 187 | 128 | 58 |
| Only index persons | 174 | 120 | 54 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 55.32 | 54.91 | 55.89 |
| Only index persons | 54.52 | 53.90 | 55.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 37 | 25 | 12 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 55.67 | 54.79 | 57.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
15
10
24.55
17.79
1.3
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
12
12.62
9.47
1.4
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
11
12.09
8.48
1.2
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
44
7.02
7.90
1.9
1.6
titre
286.7
829.1
—
6
11
(3004588) Protein electrophoresis panel - Serum or Plasma
10
13
10.17
7.50
2.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
10
11.42
5.11
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
11
10.36
4.88
1.2
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
8
12.31
4.78
1.3
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
26
134
4.16
3.96
8.8
4.7
%
2.8
2.8
0.01
26
125
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
5
13.92
3.90
1.0
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
26
136
4.07
3.83
9.1
5.0
%
8.6
8.4
0.11
26
127
(42870588) Differential panel, method unspecified - Blood
22
103
3.80
3.82
8.7
4.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
43
4.12
3.68
1.6
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
25
130
3.85
3.66
9.2
4.5
%
0.7
0.6
0.34
25
120
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
6
11.59
3.63
3.2
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
7
9.92
3.39
1.2
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
11
7.54
3.35
1.1
1.3
g/l
0.2
0.3
—
7
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
14
53
3.64
3.24
1.6
1.8
mg/l
0.2
0.7
—
9
43
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
12
6.90
3.18
1.1
1.3
g/l
1.1
1.2
—
7
12
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
8
8.66
3.18
1.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
17
74
3.40
3.18
1.5
1.9
umol/l
7245.7
9414.2
0.07
17
62
(3022313) Gas panel - Capillary blood
5
6
9.37
2.83
2.8
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
11
6.26
2.65
1.2
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
23
130
3.03
2.65
3.1
3.9
g/l
36.3
35.9
0.10
17
122
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
113
2.99
2.64
2.5
1.6
pmol/l
83.5
93.7
0.51
12
52
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
8
7.00
2.45
2.4
1.9
—
—
—
0
0
(3012544) pH of Venous blood
8
23
4.14
2.43
1.3
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
22
129
2.74
2.26
5.3
4.5
mmol/l
1.2
1.2
0.44
22
121
(3026008) Bacteria identified in Urine by Culture
17
88
2.72
2.21
4.2
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
32
3.38
2.18
2.3
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
31
229
3.17
2.15
6.6
4.4
mm/h
11.6
10.7
0.18
31
209
(3020682) Albumin/Creatinine [Ratio] in Urine
15
74
2.73
2.12
4.1
3.7
mg/mmol
5.7
10.3
—
10
46
(3000991) Gas panel - Venous blood
7
22
3.67
1.99
1.9
3.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
14
69
2.66
1.97
3.5
2.8
mg/l
37.1
90.7
—
7
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
13
63
2.64
1.87
1.5
1.3
iu/ml
26.8
30.2
—
6
24
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
30
3.11
1.85
1.1
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
13
4.27
1.77
3.4
3.5
e6/l
0.2
0.1
—
5
13
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18
105
2.39
1.75
2.9
3.7
ng/l
38.5
26.6
0.20
11
75
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
27
189
2.59
1.75
4.0
3.6
—
—
—
0
0
(3019225) pH of Specimen
7
25
3.21
1.75
2.7
5.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
32
2.90
1.72
1.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
5
14
3.95
1.67
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
18
108
2.30
1.62
1.9
3.3
u/l
46.9
32.0
0.33
18
100
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
11
54
2.48
1.51
1.6
1.2
u/ml
2.0
15.1
—
6
22
(3037467) Urinalysis macro (dipstick) panel - Urine
28
212
2.31
1.45
5.6
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
71
2.28
1.42
3.1
2.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
19
2.88
1.26
2.0
5.2
mmol/l
23.8
25.3
—
5
19
(40760892) CBC W Ordered Manual Differential panel - Blood
12
67
2.17
1.22
1.9
4.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
20
2.72
1.19
1.2
1.1
—
—
—
0
0
(3013512) EKG study
13
78
2.03
1.10
3.6
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
20
140
1.93
1.10
2.6
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
11
63
2.06
1.04
1.3
1.2
g/l
2.0
2.5
—
6
34
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
36
2.16
1.03
1.1
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
97
0.44
0.95
3.8
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
8
43
2.09
0.95
1.3
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
14
94
1.79
0.82
3.2
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
91
0.48
0.80
3.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
43
1.77
0.71
1.3
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
19
144
1.66
0.71
4.9
3.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
28
1.90
0.69
5.2
4.6
%
33.2
32.8
—
5
18
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
30
1.77
0.64
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.62
0.0
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
6
38
1.69
0.57
3.2
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
126
0.62
0.56
3.9
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
48
1.56
0.50
1.3
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
10
71
1.56
0.45
5.7
5.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
33
1.59
0.43
1.2
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
4.0
—
107.6
—
0
9
(3000494) Fungus identified in Specimen by Culture
5
34
1.54
0.42
2.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
16
0.00
0.42
0.0
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
109
1.46
0.42
3.8
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
34.8
—
0
17
(3011397) Hemoglobin [Presence] in Urine by Test strip
5
72
0.65
0.29
6.0
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
31
289
1.45
0.28
8.5
4.9
mmol/mol
39.0
38.8
0.04
31
272
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
1.6
—
44.9
—
0
11
(3000764) Benzodiazepines [Presence] in Urine
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4034850)
0
14
0.00
0.20
0.0
21.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
24
258
0.80
0.17
25.8
15.8
%
14.0
14.1
0.09
24
251
(3009542) Hematocrit [Volume Fraction] of Blood
28
293
0.82
0.17
23.3
13.2
%
38.6
39.7
0.48
18
230
(40758558) Short blood count panel - Blood
9
81
1.15
0.17
11.1
7.8
—
—
—
0
0
(3044889) 12 lead EKG panel
24
222
1.23
0.16
3.7
3.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
32
324
0.91
0.10
20.3
11.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
64
1.12
0.09
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
31
301
1.18
0.08
5.2
4.3
mmol/l
5.7
5.8
0.26
31
281
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12
132
0.87
0.08
5.2
3.4
—
—
—
0
0
(3015736) pH of Urine
13
131
0.99
0.00
4.5
3.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4306422)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.6
—
221.0
—
0
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
31
312
0.96
0.00
5.3
4.3
mmol/l
1.4
1.5
0.85
31
287
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.2
—
17.8
—
0
5
(3003181) Sodium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
75.5
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
64
0.93
0.00
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
3.1
—
0
6
(3041096) Erythrocytes [Presence] in Urine by Automated
10
100
1.00
0.00
4.1
3.0
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.8
—
36.8
—
0
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
30
302
0.97
0.00
4.9
3.9
mmol/l
1.3
1.3
0.00
30
276
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
9
0.00
-0.00
0.0
1.4
—
94.6
—
0
9
(3035637) Corticotropin [Mass/volume] in Plasma
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
3.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
3.3
—
23.5
—
0
9
(3014051) Protein [Presence] in Urine by Test strip
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
9
0.00
-0.00
0.0
5.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
9
0.00
-0.00
0.0
1.4
—
222.7
—
0
9
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_MUCINOSISOFSKIN and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_MUCINOSISOFSKIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_MUCINOSISOFSKIN – Mucinosis of skin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data